The records of 100 patients (161 eyes) with uveitis were reviewed retrospectively to determine the prevalence of increased intraocular pressure, the forms of uveitis most commonly associated with glaucoma, and the forms that require specific glaucoma therapy. This study was undertaken to obtain data on the prevalence of increased intraocular pressure in patients with uveitis and to identify the forms of uveitis most commonly associated with glaucoma and that require specific glaucoma therapy. With such information rational approaches to the management of uveitis-related glaucoma can be planned.
commonly associated with glaucoma, and the forms that require specific glaucoma therapy. Secondary glaucoma was present in 23 patients (31 eyes): three of24 patients with acute uveitis (three eyes, 12% of acute uveitis patients) and 20 of 76 patients with chronic uveitis (28 eyes, 26% of chronic uveitis patients). Eighteen patients (26 eyes, 78% of glaucoma patients) with chronic uveitis required long-term medical therapy to control intraocular pressure. Three patients (three eyes, 12% of glaucoma patients) with acute uveitis required short-term therapy to control intraocular pressure. The remaining two patients had transient increases in intraocular pressure that did not require treatment or that responded to treatment of intraocular inflammation alone. One patient with chronic uveitis (two eyes, 4% of glaucoma patients) required filtering surgery. At least five patients (eight eyes, 22% ofglaucoma patients) had glaucomatous visual field defects. The results of this survey are consistent with the concept that secondary glaucoma is a management problem in patients with anterior segment inflammation and chronic rather than acute uveitis. An algorithm for the management of increased intraocular pressure in patients with uveitis is proposed.
uveitis referred to and examined by one author (GNH) 39 Adjunctive methods of treatment are under investigation to decrease postoperative inflammation and fibrosis after glaucoma filtering surgery. They include the use of locally administered agents such as 5-fluorouracil40 and triamcinolone4' in the preoperative and postoperative periods. In future these regimens may be shown to improve filter survival in patients with uveitic glaucoma.
On the basis of these concepts the authors propose a stepwise approach to the evaluation and treatment of increased intraocular pressure in patients with uveitis (Fig 1) . Because steroid associated glaucoma is apparently uncommon, and because the effect of prolonged or increased inflammation is potentially worse than a transient steroid induced rise in intraocular pressure, one should first increase steroid dosage and observe both intraocular pressure and inflammation. In cases where severe glaucomatous nerve damage previously exists, antiglaucoma therapy may be included while steroids are increased and then withdrawn if pressure decreases.
If intraocular pressure remains unchanged or rises with increased steroids, and inflammation is stable or improved, steroid therapy should be reduced to 
